Ozempic
- Home
- Services
- Ozempic
Don’t think much, have a query? Call us now!

Looking for Ozempic weight loss treatment in Delhi? At The Face Clinic in Hauz Khas, South Delhi, Dr. Reema Arora offers highly personalized, doctor-led Ozempic® (semaglutide) weight loss programs engineered for gradual, medically supervised fat loss and long-term weight management.
Ozempic is a prescription-only GLP-1 receptor agonist that safely reduces appetite, regulates insulin signaling, and controls intensive food cravings. Because sustainable weight management requires continuous clinical tracking rather than simple medication access, our programs are structured as comprehensive, end-to-end medical care protocols. Each customized treatment plan includes mandatory baseline diagnostics, internal medicine or endocrinologist clearance, personalized weekly dose titration, and rigorous clinical follow-ups tailored to your metabolic profile.
Patients from Delhi NCR, Gurgaon, Noida, and nearby areas visit our South Delhi clinic for structured semaglutide protocols focused on safe, realistic, and clinically monitored results. Patients researching semaglutide treatment, personalized pricing models, and realistic expectations can also explore our detailed guide on Ozempic cost in India.
Get your personalised treatment plan, exact cost, and medical eligibility assessment from our clinic team.
Ozempic® (semaglutide) is a prescription GLP-1–based medication that may be used for medically supervised weight loss in eligible patients following a comprehensive doctor’s assessment. In 2026, with the increasing availability of semaglutide and affordable generic options in India, it has become a widely used and clinically trusted approach for patients seeking ozempic weight loss in delhi under proper medical supervision.
Safe use requires a doctor-led medical weight loss program, including screening for contraindications, gradual dose escalation based on tolerance, and regular clinical monitoring to ensure safety and effectiveness.
At The Face Clinic, Hauz Khas, Dr. Reema Arora provides a structured, medically supervised approach with comprehensive evaluation, personalised dosing, and long-term metabolic support, ensuring results that are safe, sustainable, and best for you.
When combined with nutrition guidance, lifestyle optimisation, and follow-up, GLP-1 therapy supports gradual fat loss and improved metabolic regulation. Most patients achieve progressive, clinically monitored weight reduction over several months.
Eligibility is determined through medical evaluation, including BMI, metabolic health, medications, pregnancy planning, and contraindications such as MEN2 and pancreatitis risk factors.
A personalised medical consultation is essential to determine suitability and create an effective treatment plan.

Ozempic weight loss treatment uses Ozempic® (semaglutide), a GLP-1 receptor agonist medication, originally developed for the treatment of type 2 diabetes. Within medically supervised weight-management programs, semaglutide may also be prescribed for weight loss in eligible patients, helping regulate appetite, satiety signals, and metabolic pathways that influence body weight.
Semaglutide mimics the action of the natural glucagon-like peptide-1 (GLP-1) hormone, which is released after eating and helps coordinate hunger signals, digestion, and metabolic balance. Through several physiological mechanisms, Ozempic can support gradual and sustainable weight reduction.
How Ozempic works in the body:
Slowing Gastric Emptying
Metabolic Regulation and Insulin Response
Reduced Reward-Driven Eating
As these mechanisms stabilise appetite signals and metabolic regulation, many patients naturally consume fewer calories while maintaining nutritional balance, supporting gradual and sustainable fat loss rather than rapid or extreme weight reduction.
At specialised doctor-supervised weight-loss clinics in Delhi, Ozempic therapy is delivered through careful patient selection, personalised dosing, and ongoing medical monitoring to ensure treatment remains safe and clinically appropriate.
When used responsibly under medical supervision, Ozempic (semaglutide) therapy supports gradual, sustainable weight reduction and long-term metabolic health rather than short-term or unsupervised weight loss.
GLP-1 medications mimic the action of the natural glucagon-like peptide-1 hormone, which is released after eating and helps regulate hunger, digestion, and metabolic signalling. Through several coordinated mechanisms, Ozempic helps patients reduce calorie intake while maintaining balanced nutrition.
To understand how these medications regulate appetite and metabolism in detail, explore our complete guide on GLP-1 weight loss.
GLP-1 therapies may also influence reward pathways in the brain associated with highly palatable foods. Many patients report reduced cravings for sugary or high-calorie foods, which can reinforce healthier eating behaviours during treatment.
Who it’s for:
Adults with excess weight or metabolic risk who are medically eligible after a comprehensive doctor evaluation.
Who should avoid it:
Pregnancy or planning pregnancy, certain thyroid conditions (including MEN2), history of pancreatitis, or other contraindications identified during screening.
How it works:
Semaglutide is a GLP-1 receptor agonist that helps reduce appetite, improve satiety, and regulate metabolic signals—supporting gradual fat loss as part of a doctor-led Ozempic and semaglutide weight loss program, including newer affordable generic options available in India (2026).
Monitoring includes:
Structured dose titration, side-effect tracking, nutrition guidance, and ongoing metabolic monitoring under clinical supervision to optimise safety and results.
Cost & results:
Ozempic and semaglutide treatment cost in Delhi varies depending on dosage, brand (including generic options), and program design. Most patients achieve progressive, clinically monitored weight loss over 3–6 months, with results improving further under structured follow-up and lifestyle support.
Where:
Doctor-led Ozempic and semaglutide weight loss clinic in Hauz Khas, South Delhi, serving Delhi NCR and nearby patients.
GLP-1–based treatments differ in mechanism, potency, availability, and clinical suitability. A doctor’s role is to carefully match your metabolic profile, medical history, tolerance, risk factors, weight-loss goals, and long-term safety considerations before selecting the most appropriate treatment approach.
Patients exploring newer dual-action GLP-1 therapies can also learn more about mounjaro weight loss in Delhi and whether tirzepatide-based treatment may be appropriate following a detailed medical evaluation.
Comparisons between Ozempic, Wegovy, and Mounjaro should remain clinical, evidence-based, and patient-centric rather than promotional.
You can also explore how Ozempic treatment is evolving in India in our article on Ozempic treatment.
Patients comparing semaglutide and tirzepatide therapies can also read our detailed guide on Wegovy vs Mounjaro to understand differences in mechanism, weight-loss response, and suitability.
Weeks 1–4: Appetite regulation and dose adjustment. Many patients notice reduced hunger and fewer cravings as dosing begins and is titrated.
Weeks 5–8: Steady fat-loss phase for some patients, with visible changes. Monitoring helps optimise dose and manage side effects.
Weeks 9–12: Stabilisation and habit reinforcement. Some patients experience plateaus; doctor guidance helps maintain sustainable progress.

Get your personalised treatment plan, exact cost, and medical eligibility assessment from our clinic team.
When prescribed and monitored by a qualified doctor, Ozempic is generally well tolerated in eligible patients. Most side effects occur during dose escalation and are temporary.
Ozempic is contraindicated in patients with certain thyroid conditions, including a personal or family history of medullary thyroid carcinoma (MTC) or MEN2.
Seek medical review urgently for severe or persistent abdominal pain, repeated vomiting, symptoms suggestive of gallbladder disease or pancreatitis, or significant dehydration.
Medical supervision enables dose adjustment, supportive guidance, and early intervention, reducing avoidable risk.
For individuals exploring semaglutide weight loss near me or injectable weight loss near me in South Delhi, treatment should always be guided by a qualified medical professional after proper evaluation.
Understanding Ozempic & Type 2 Diabetes – What Non-Diabetic Patients Should Know
Ozempic is approved for diabetes management. Weight-management use is determined by a doctor based on individual suitability. For non-diabetic patients, appropriate screening and monitoring are essential.
Does Ozempic Improve Skin, Facial Fat Distribution & Body Composition?
At The Face Clinic, Ozempic is part of a medical journey, not a one-time injection.
Structured follow-ups to support adherence and long-term stability
Long-Term Considerations for Maintaining Weight Loss After Ozempic
Ozempic weight loss cost in Delhi typically ranges from ₹7,000 to ₹12,500 per week depending on dose and medical supervision. At The Face Clinic, Dr. Reema Arora offers doctor-supervised GLP-1 treatment for safe and effective fat loss.
| Plan Name | Inclusions | Duration | Price Range (INR) |
|---|---|---|---|
| Starter Plan BEGINNER |
4 weekly Ozempic injections 1 doctor consultation Weight & metabolic assessment | 4 Weeks | ₹48,000 – ₹60,000 |
| Pro Plan POPULAR |
12 weekly Ozempic injections 2 in-depth reviews with the doctor Diet & lifestyle guidance | 12 Weeks | ₹1,25,000 – ₹1,45,000 |
| Concierge Plan PREMIUM |
12-week Ozempic protocol IV fat burner sessions EMS + Body contouring add-ons Dedicated care team access | 3 Months (Customised) | On Request |
| Mounjaro Upgrade ADVANCED |
Available on request Higher potency GLP-1 (Tirzepatide) Subject to doctor approval | Flexible | ₹65,000 – ₹85,000 per month |
All treatment plans include comprehensive medical eligibility screening and clinical assessment by Dr. Reema Arora, along with mandatory pre-treatment evaluation or clearance by an Internal Medicine specialist or Endocrinologist, ensuring safe and appropriate treatment planning.
Note: Prices vary based on dosage, metabolism, and weight loss goals; therefore, the price of Ozempic injection in Delhi, India may vary for each patient.
Prices are valid until September 2026.

For real-life transformation experiences and lifestyle changes, read our article on Ozempic weight loss transformation journeys in India.

Ozempic is a prescription-only medication in India, approved for type 2 diabetes. It may be prescribed off-label for weight loss by qualified doctors after a detailed medical evaluation. At our Delhi clinic, treatment is strictly doctor-led, indication-based, and aligned with safety protocols.
Ozempic is a GLP-1 receptor agonist (semaglutide) that reduces appetite, slows gastric emptying, and improves satiety signaling. This leads to lower calorie intake and gradual, medically supervised fat loss, especially when combined with structured nutrition and lifestyle guidance.
Eligibility is based on BMI, metabolic profile, and medical history. It is typically considered for individuals with BMI ≥30, or ≥27 with obesity-related conditions. A doctor-led assessment in Delhi is essential to determine suitability and ensure safe initiation.
Ozempic weight loss Treatment in Delhi typically ranges from ₹7,000 to ₹12,500 per week, depending on dose escalation and clinical requirements. Costs may vary when included within a comprehensive doctor-supervised program with monitoring, nutrition, and follow-up care.
Common side effects include nausea, vomiting, reduced appetite, constipation, and gastrointestinal discomfort, especially during dose escalation. These are usually temporary. Rare but important risks are discussed during consultation to ensure safe, individualised, doctor-led treatment.
Ozempic may not be suitable for individuals with a history of medullary thyroid carcinoma, MEN2 syndrome, pancreatitis, or certain gastrointestinal conditions, and is generally avoided during pregnancy. A doctor-led medical screening in Delhi is essential to identify contraindications and ensure safe prescribing.
Ozempic and Wegovy both contain semaglutide, while Mounjaro contains tirzepatide. These medications differ in dosing, weight-loss response, treatment protocols, and clinical suitability. A doctor can help determine which option may be appropriate based on individual weight-loss goals and metabolic health.
Semaglutide-based weight loss treatments may be available in India through prescription-based medical programs and qualified clinics, depending on clinical suitability and product availability.
Weight-loss results can vary depending on starting weight, lifestyle habits, metabolic health, dosage progression, and treatment consistency. Many patients experience gradual fat loss over several weeks to months when treatment is combined with a structured medical weight-loss program.
Ozempic treatment duration varies from person to person. Some individuals may use it for a few months as part of a structured weight-loss plan, while others may require longer-term medical supervision depending on their goals, response to treatment, and metabolic health.
Ozempic consultations and medically supervised weight-loss programs may be available through specialised clinics in Delhi. A consultation helps determine eligibility, treatment suitability, and the most appropriate approach for long-term weight management.
Ozempic treatment should only be prescribed after evaluation by a qualified medical professional experienced in obesity management, metabolic health, and medically supervised weight-loss treatments.

Wegovy (semaglutide) weight-loss injection
(availability updates)
All treatments are subject to individual variation. Outcomes are determined following clinical evaluation by a qualified doctor.